Amid growing reports of prescription and over-the-counter drugs being contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen, manufacturers are looking for ways to make sure their products are safe. In a recent report by Chemical & Engineering News (C&EN), investigators looked
A New Hampshire man recently filed a new Zantac lawsuit in the U.S. District for the Southern District of Florida. He claims that after using the product as directed for years, he suffered from serious injuries stemming from what he claims were unsafe quantities of…
A New York plaintiff recently filed a metformin class-action lawsuit on behalf of himself and all others who took the type 2 diabetes medication manufactured by Ascend Laboratories. The plaintiff claims that the defendants market their medication as safe, but based on scientific findings submitted…
In a new Zantac lawsuit filed in the U.S. District Court for the Southern District of Florida, the plaintiff claims he suffered from serious injuries after taking Zantac (ranitidine) for years. He blames the manufacturers of the acid-reducing drug for failing to warn about the…
On Dec. 31, 2018, Bayer stopped selling and distributing Essure—a permanent birth control device—because lawsuits and plummeting sales made the “Essure business no longer sustainable.” The company made the decision after thousands of women complained that the device caused dangerous and painful sid
Baby powder manufacturer Johnson & Johnson (J&J) currently faces thousands of lawsuits filed by plaintiffs who claim to have suffered serious injuries after using talc-based products for years. J&J has continued to maintain that its products are safe, but according to a recent study, participants…
Judge Freda L. Wolfson, who is presiding over centralized pretrial proceedings in the Johnson & Johnson (J&J) talcum powder litigation in New Jersey, recently ordered that the plaintiffs can move forward with their claims, though they will have to adhere to some limits on expert…
According to a pretrial order issued on April 3, 2020, Zantac’s consolidated litigation—which is proceeding in the Southern District of Florida—will continue to move forward despite changes associated with COVID-19. U.S. District Judge Robin L. Rosenberg, who was appointed to oversee the proceedings
An Alabama man recently became one of the latest individuals to file a new Zantac lawsuit seeking compensation for serious injuries he blames on the heartburn medication. The case is pending in the U.S. District Court for the Northern District of Alabama, but will be…
On March 9, 2020, the U.S. Food and Drug Administration (FDA) issued a new update on the results of its testing of talc-containing cosmetic products for the possible presence of asbestos. The results showed that 43 of the samples were negative, but 9 were positive…
Almost a year after online pharmacy Valisure notified the U.S. Food and Drug Administration (FDA) that it had found unsafe levels of a carcinogen in Zantac (ranitidine) samples tested, the FDA has requested that all ranitidine products be pulled from the market immediately. The recall…
A new Zantac lawsuit filed in the U.S. District Court for the District of Columbia involves claims that the manufacturers of the heartburn medication failed to warn consumers about a potential increased risk of cancer. The plaintiff, a resident of Washington D.C., states that she…
